MUMBAI, India, April 20 -- Intellectual Property India has published a patent application (202411075838 A) filed by Birla Institute Of Technology & Science, Pilani, Rajasthan, on Oct. 7, 2024, for 'multifunctional hybrid nanozymes for mrsa-infected diabetic wound healing.'
Inventor(s) include Biswas, Swati; Ghosh, Balaram; Kothari, Prafful Pradeep; and Banerjee, Tonmoy.
The application for the patent was published on April 17, under issue no. 16/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to stabilized multifunctional hybrid nanozymes. Specifically, the present invention relates to multifunctional hybrid nanozymes comprising a dual metal-containing nanoflower coated with a photothermal agent and further loaded with a photosensitizer, wherein the nanozyme having peroxidase (POD)-like enzymatic activity and catalase (CAT)-like enzymatic activity. The present invention further relates to a method of synthesizing the same and a pharmaceutical composition comprising the same. The pharmaceutical composition may be used to treat MRSA infection in diabetic wounds."
Disclaimer: Curated by HT Syndication.
